Yongjin Xu

1.5k total citations
49 papers, 745 citations indexed

About

Yongjin Xu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Yongjin Xu has authored 49 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Organic Chemistry and 16 papers in Oncology. Recurrent topics in Yongjin Xu's work include Metal complexes synthesis and properties (8 papers), Computational Drug Discovery Methods (7 papers) and Synthesis and biological activity (5 papers). Yongjin Xu is often cited by papers focused on Metal complexes synthesis and properties (8 papers), Computational Drug Discovery Methods (7 papers) and Synthesis and biological activity (5 papers). Yongjin Xu collaborates with scholars based in China, United States and Sweden. Yongjin Xu's co-authors include Mark A. Johnson, Lu Gao, Zhenlei Song, Morten Grøtli, Joakim Andréasson, Chunxia Gao, Bei‐Sheng Kang, Zhiping Yin, Xiaowu Dong and Jinxin Che and has published in prestigious journals such as The Science of The Total Environment, Cancer Research and Chemical Communications.

In The Last Decade

Yongjin Xu

49 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongjin Xu China 17 334 285 192 144 119 49 745
Werngard Czechtizky Germany 18 394 1.2× 362 1.3× 134 0.7× 30 0.2× 112 0.9× 49 871
Daniel Alencar Rodrigues Brazil 14 463 1.4× 523 1.8× 66 0.3× 478 3.3× 102 0.9× 30 1.1k
Benjamin P. Fauber United States 16 637 1.9× 384 1.3× 87 0.5× 280 1.9× 84 0.7× 24 1.3k
Mimi L. Quan United States 22 338 1.0× 608 2.1× 97 0.5× 82 0.6× 91 0.8× 48 1.4k
Keizo Koya United States 19 627 1.9× 406 1.4× 59 0.3× 205 1.4× 115 1.0× 31 1.2k
Ana Conejo‐García Spain 20 599 1.8× 404 1.4× 85 0.4× 127 0.9× 61 0.5× 61 998
Bernard Pirard Switzerland 16 536 1.6× 165 0.6× 194 1.0× 212 1.5× 40 0.3× 31 915
Yi An United States 14 216 0.6× 320 1.1× 33 0.2× 148 1.0× 146 1.2× 32 707
Mathias Färnegårdh Sweden 13 531 1.6× 105 0.4× 90 0.5× 275 1.9× 95 0.8× 14 1.1k
Kristi Leonard United States 15 253 0.8× 338 1.2× 41 0.2× 183 1.3× 70 0.6× 24 699

Countries citing papers authored by Yongjin Xu

Since Specialization
Citations

This map shows the geographic impact of Yongjin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjin Xu more than expected).

Fields of papers citing papers by Yongjin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjin Xu. The network helps show where Yongjin Xu may publish in the future.

Co-authorship network of co-authors of Yongjin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjin Xu. A scholar is included among the top collaborators of Yongjin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjin Xu. Yongjin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yongjin, Shichang Kang, Jianxi Zhu, et al.. (2024). Recovery of rare earth elements from ion-adsorption deposits using electro kinetic technology: A comparative study on leaching agents. Chemical Engineering Journal. 499. 156094–156094. 7 indexed citations
2.
Kang, Shichang, Bowen Ling, Gaofeng Wang, et al.. (2024). Transport dynamics of rare earth elements in weathering crust soils. The Science of The Total Environment. 930. 172843–172843. 4 indexed citations
3.
Fleming, Cassandra L., Yongjin Xu, Tord Inghardt, et al.. (2024). All-photonic kinase inhibitors: light-controlled release-and-report inhibition. Chemical Science. 15(18). 6897–6905. 5 indexed citations
4.
Xu, Yongjin, Yang Lu, Xinxin Jin, et al.. (2022). Design, synthesis and biological evaluation of sulfonamides inhibitors of XPO1 displaying activity against multiple myeloma cells. European Journal of Medicinal Chemistry. 235. 114257–114257. 8 indexed citations
5.
Xu, Yongjin, Haifeng Chen, Junjie Hu, et al.. (2022). Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. European Journal of Medicinal Chemistry. 244. 114847–114847. 24 indexed citations
6.
Zhu, Cheng‐Liang, Xiaomin Luo, Tian Tian, et al.. (2022). Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degrader. European Journal of Medicinal Chemistry. 238. 114459–114459. 18 indexed citations
7.
8.
Xu, Yongjin, Chunxia Gao, Joakim Andréasson, & Morten Grøtli. (2018). Synthesis and Photophysical Characterization of Azoheteroarenes. Organic Letters. 20(16). 4875–4879. 31 indexed citations
9.
Ma, Xiaolei, Lili Xie, Charles Wartchow, et al.. (2017). Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit. Scientific Reports. 7(1). 9385–9385. 20 indexed citations
10.
Han, Wooseok, Yu Ding, Yongjin Xu, et al.. (2016). Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design. Journal of Medicinal Chemistry. 59(7). 3034–3045. 15 indexed citations
11.
Han, Wooseok, Daniel L. Menezes, Yongjin Xu, et al.. (2016). Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 26(3). 742–746. 20 indexed citations
13.
Mavunkel, Babu, John Perumattam, Xuefei Tan, et al.. (2009). Piperidine-based heterocyclic oxalyl amides as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1059–1062. 21 indexed citations
14.
Levy, Daniel E., Qing Lu, Zheng Chen, et al.. (2008). Aryl–indolyl maleimides as inhibitors of CaMKIIδ. Part 1: SAR of the aryl region. Bioorganic & Medicinal Chemistry Letters. 18(7). 2390–2394. 14 indexed citations
15.
Levy, Daniel E., Qing Lu, Zheng Chen, et al.. (2008). Aryl-indolyl maleimides as inhibitors of CaMKIIδ. Part 2: SAR of the amine tether. Bioorganic & Medicinal Chemistry Letters. 18(7). 2395–2398. 9 indexed citations
16.
Shan, Yuhua, Junquan Sun, Yongjin Xu, Yonggang Cui, & Feng Lin. (2005). ETHYLENE POLYMERIZATION AND COPOLYMERIZATION WITH POLAR MONOMERS BY A NEUTRAL NICKEL CATALYST COMBINED WITH CO-CATALYST OF Ni(COD)2 OR AL(i-Bu)3. Chinese Journal of Polymer Science. 23(3). 301–310. 2 indexed citations
17.
Xu, Yongjin & Hua Gao. (2003). Dimension related distance and its application in QSAR/QSPR model error estimation. QSAR & Combinatorial Science. 22(4). 422–429. 11 indexed citations
19.
Hu, Yonghan, Bei‐Sheng Kang, Xue‐Tai Chen, et al.. (1993). Structural comparison to the molybdenum site of nitrogenase. Synthesis and crystal structure of binuclear oxomolybdenum(V) complex with both o‐mercaptophenolate and alkoxide ligands. Chinese Journal of Chemistry. 11(2). 137–143. 4 indexed citations
20.
Kang, Bei‐Sheng, Yonghan Hu, Linghong Weng, et al.. (1992). Triply bridged (O,O′,S)-binuclear oxomolybdenum(V) complexes containing o-mercaptophenol ligands. Journal of Inorganic Biochemistry. 46(4). 231–242. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026